Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levemir Titration Algorithms in Korean T2DM
NCT01868542Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2013
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2013; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01868542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868542.